173
Views
6
CrossRef citations to date
0
Altmetric
Eco/Toxicology

Protective effects of Flacourtia indica on doxorubicin-induced cardiotoxicity in rats

, , &
Pages 1014-1025 | Received 22 Jul 2011, Accepted 18 Mar 2012, Published online: 23 Apr 2012
 

Abstract

This study examined the cardioprotective activity of an ethanolic extract of Flacourtia indica (FI) against doxorubicin (DOX)-induced myocardial infarction (MI) in rats. Different phytoconstituents were identified by gas chromatography-mass spectroscopy. DOX is a chemotherapeutic agent which produces free oxygen radicals that result in serious dose-limiting cardiotoxicity. A DOX dose of 20 mg kg−1 body weight is used to bring significant changes in biochemical parameters, endogenous antioxidants, and moderate necrosis in the heart. The pretreatment with FI at two doses (250 and 500 mg kg−1) to DOX-treated rats significantly prevented the altered biochemical parameters such as serum marker enzymes serum glutamate-pyruvate transaminase, serum glutamate oxaloacetate transaminase, creatine phosphokinase, and lactate dehydrogenase, lipid profile such as low-density lipoprotein, very low-density lipoprotein, triglycerides, high-density lipoprotein, total cholesterol, and antioxidant parameters such as superoxide dismutase, glutathione, catalase, glutathione peroxidase, and malondialdehyde to near normal level. Serum urea, uric acid, and alkaline phosphate which are increased on DOX administration registered near normal values on pretreatment with FI. In conclusion, these data suggest that the ethanol extract of FI can prevent heart damage by DOX-induced MI in rats and this is likely mediated through its antioxidant activities.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.